drugset / Trial / NCT00398645

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

NCT00398645

Phase 2 Completed 648 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindTreatment

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Timeline

Start
2006-11-15
Primary completion
2007-08-01
Completion
2007-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified 200 ug Inhaled
Subject Fluticasone Furoate Other / unclassified 400 ug Inhaled

Indications